SALMETEROL/FLUTICASONE PROPIONATE EASYHALER® : DOSE CONSISTENCY UNDER SIMULATED REAL-LIFE CONDITIONS

被引：0

作者：

Haikarainen, J. ^{[1
]}

Happonen, A. ^{[2
]}

Rytila, P. H. ^{[2
]}

机构：

[1] Orion Pharma, Orion Corp, Espoo, Finland

[2] Orion Pharma, Orion Corp, Kuopio, Finland

来源：

THORAX | 2018年 / 73卷

关键词：

D O I：

10.1136/thorax-2018-212555.326

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

P168

引用

页码：A193 / A193

页数：1

共 50 条

[21] Investigations into the Formulation of Metered Dose Inhalers of Salmeterol Xinafoate and Fluticasone Propionate Microcrystals
Darragh Murnane
Gary P. Martin
Christopher Marriott
Pharmaceutical Research, 2008, 25 : 2283 - 2291
[22] In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial
Jogi, Rain
Lahelma, Satu
Vahteristo, Mikko
Happonen, Anita
Haikarainen, Jussi
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (02) : 88 - 98
[23] Quality of life as measure of therapeutical effects of fluticasone propionate and salmeterol in the treatment of asthma
Postolache, P
Petrescu, O
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R481 - R481
[24] The impact of salmeterol/fluticasone propionate combination on quality of life of asthma and COPD patients
Casey, J.
Redmond, S.
VALUE IN HEALTH, 2007, 10 (06) : A310 - A311
[25] A COMPARISON OF CLINICAL PROFILES, MEDICATION USE AND SYMPTOMOLOGY IN ASTHMA PATIENTS PRESCRIBED LOW/MODERATE DOSE FLUTICASONE PROPIONATE/SALMETEROL OR MODERATE/HIGH DOSE FLUTICASONE PROPIONATE
Burke, J. P.
Stanford, R. H.
Polos, P. G.
Astry, C. L.
Riedel, A.
VALUE IN HEALTH, 2010, 13 (03) : A196 - A196
[26] Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
van Noord, JA
Schreurs, AJM
Mol, SJM
Mulder, PGH
THORAX, 1999, 54 (03) : 207 - 212
[27] A comparison of three rapid bacterial detection methods under simulated real-life conditions
Schmidt, Michael
Hourfar, Michael K.
Nicol, Sven-Boris
Wahl, Alexandra
Heck, Julia
Weis, Christina
Tonn, Torsten
Spengler, Hans-Peter
Montag, Thomas
Seifried, Erhard
Roth, W. Kurt
TRANSFUSION, 2006, 46 (08) : 1367 - 1373
[28] Comparative Resource Utilization in Medicaid-Eligible Patients With Asthma Treated With Fixed-Dose Fluticasone Propionate/Salmeterol or Fluticasone Propionate Monotherapy
Stanford, Richard H.
Riedel, Aylin A.
Johnson, Jonathan C.
Astry, Calvin L.
CLINICAL THERAPEUTICS, 2010, 32 (10) : 1782 - 1793
[29] Comparison of resource utilization of fluticasone propionate/salmeterol compared with fluticasone propionate alone: Analysis of 64,689 real world users.
Riedel, A.
Stanford, R.
Stempel, D.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A61 - A61
[30] 'Real-Life' Effectiveness of Qvar, Beclomethasone and Fluticasone
Kemp, L.
Price, D.
Sims, E.
Dorinsky, P.
von Ziegenweidt, J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) : 729 - 729

← 1 2 3 4 5 →